Skip to content

NANO NUCLEAR ENERGY INC.: 10-Q filed 2024-06-20

What NANO NUCLEAR ENERGY INC. reported in its quarterly report filed 2024-06-20 (fiscal Q2 2024): 24 published measures, 67 facts as tagged in accession 0001493152-24-024530.

This filing

Form
10-Q (quarterly report)
Filed
2024-06-20
Fiscal period
fiscal Q2 2024
Accession
0001493152-24-024530 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANO NUCLEAR ENERGY INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-03-318,870,018USD
At 2023-09-307,233,652USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-03-312,234,050USD
At 2023-09-30225,005USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-03-316,635,968USD
At 2023-12-312,801,139USD
At 2023-09-302,008,647USD
At 2023-03-312,394,950USD
At 2022-12-313,023,400USD
At 2022-09-302,109,676USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-1,677,628USD91
2023-10-01 to 2024-03-31-2,991,573USD183
2022-10-01 to 2023-09-30-6,250,401USD365
2023-01-01 to 2023-03-31-1,520,434USD90
2022-10-01 to 2023-03-31-2,204,579USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-10-01 to 2024-03-31-3,409,204USD183
2022-10-01 to 2023-09-303,867,573USD365
2022-10-01 to 2023-03-31-1,469,139USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-10-01 to 2024-03-312,411,437USD183
2022-10-01 to 2023-03-311,770,369USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-03-31-10,273,798USD
At 2023-09-30-7,282,225USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-01-01 to 2024-03-3123,861,244shares91
2023-10-01 to 2024-03-3123,521,208shares183
2023-01-01 to 2023-03-3122,307,508shares90
2022-10-01 to 2023-03-3121,747,734shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-01-01 to 2024-03-3123,861,244shares91
2023-10-01 to 2024-03-3123,521,208shares183
2023-01-01 to 2023-03-3122,307,508shares90
2022-10-01 to 2023-03-3121,747,734shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-0.07USD/shares91
2023-10-01 to 2024-03-31-0.13USD/shares183
2023-01-01 to 2023-03-31-0.07USD/shares90
2022-10-01 to 2023-03-31-0.1USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-0.07USD/shares91
2023-10-01 to 2024-03-31-0.13USD/shares183
2023-01-01 to 2023-03-31-0.07USD/shares90
2022-10-01 to 2023-03-31-0.1USD/shares182

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-10-01 to 2024-03-31152,457USD183
2022-10-01 to 2023-03-31669,484USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-03-316,590,005USD
At 2023-09-307,158,652USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-03-31605,459USD
At 2023-09-30225,005USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-01-01 to 2024-03-311,713,848USD91
2023-10-01 to 2024-03-313,062,760USD183
2023-01-01 to 2023-03-311,520,434USD90
2022-10-01 to 2023-03-312,204,579USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-01-01 to 2024-03-31290,539USD91
2023-10-01 to 2024-03-31810,555USD183
2023-01-01 to 2023-03-31392,900USD90
2022-10-01 to 2023-03-31520,606USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-03-3126,007,013shares
At 2023-09-3023,184,869shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-03-3116,907,165USD
At 2023-09-309,288,553USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-03-311,914,778USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-03-311,909,542USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-03-311,423,309USD91
2023-10-01 to 2024-03-312,252,205USD183
2023-01-01 to 2023-03-311,127,534USD90
2022-10-01 to 2023-03-311,683,973USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-10-01 to 2024-03-3111,878USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-10-01 to 2024-03-312,466,437USD183
2022-10-01 to 2023-03-311,820,369USD182

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2024-01-01 to 2024-03-3133,605USD91
2023-10-01 to 2024-03-3133,605USD183

Inspect the source

Entity
NANO NUCLEAR ENERGY INC. / CIK 0001923891
Captured
2026-09-21T17:36:41.601Z
SEC response SHA-256
d17454f45f10b968cff0e86cf779cf52b93a14a310df63367c6371777c01aa95

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001923891.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))